As of January 2026 MoonLake Immunotherapeutics has a market cap of A$1.84 Billion. This makes MoonLake Immunotherapeutics the world's 5652th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Jan 14th, 2026 the market cap of MoonLake Immunotherapeutics was reported to be: